UniProt ID | SAP30_HUMAN | |
---|---|---|
UniProt AC | O75446 | |
Protein Name | Histone deacetylase complex subunit SAP30 | |
Gene Name | SAP30 {ECO:0000312|HGNC:HGNC:10532} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 220 | |
Subcellular Localization | Nucleus. | |
Protein Description | Involved in the functional recruitment of the Sin3-histone deacetylase complex (HDAC) to a specific subset of N-CoR corepressor complexes. Capable of transcription repression by N-CoR. Active in deacetylating core histone octamers (when in a complex) but inactive in deacetylating nucleosomal histones.. | |
Protein Sequence | MNGFTPDEMSRGGDAAAAVAAVVAAAAAAASAGNGTGAGTGAEVPGAGAVSAAGPPGAAGPGPGQLCCLREDGERCGRAAGNASFSKRIQKSISQKKVKIELDKSARHLYICDYHKNLIQSVRNRRKRKGSDDDGGDSPVQDIDTPEVDLYQLQVNTLRRYKRHFKLPTRPGLNKAQLVEIVGCHFRSIPVNEKDTLTYFIYSVKNDKNKSDLKVDSGVH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MNGFTPDEMSRG ---CCCCCHHHHCCC | 31.09 | 23186163 | |
84 | Phosphorylation | GRAAGNASFSKRIQK CHHCCCHHHHHHHHH | 33.77 | 24719451 | |
87 | Sumoylation | AGNASFSKRIQKSIS CCCHHHHHHHHHHHC | 52.05 | - | |
87 | Sumoylation | AGNASFSKRIQKSIS CCCHHHHHHHHHHHC | 52.05 | 28112733 | |
87 | Ubiquitination | AGNASFSKRIQKSIS CCCHHHHHHHHHHHC | 52.05 | 29967540 | |
87 | Acetylation | AGNASFSKRIQKSIS CCCHHHHHHHHHHHC | 52.05 | 25953088 | |
91 | Ubiquitination | SFSKRIQKSISQKKV HHHHHHHHHHCCCCE | 47.59 | 29967540 | |
104 | Ubiquitination | KVKIELDKSARHLYI CEEEEECCCCCEEEE | 59.65 | 19608861 | |
104 | Acetylation | KVKIELDKSARHLYI CEEEEECCCCCEEEE | 59.65 | 19608861 | |
105 | Phosphorylation | VKIELDKSARHLYIC EEEEECCCCCEEEEC | 30.15 | 28857561 | |
131 | Phosphorylation | NRRKRKGSDDDGGDS HHHHCCCCCCCCCCC | 40.68 | 25159151 | |
138 | Phosphorylation | SDDDGGDSPVQDIDT CCCCCCCCCCCCCCC | 30.19 | 25159151 | |
145 | Phosphorylation | SPVQDIDTPEVDLYQ CCCCCCCCCCEEEEH | 22.98 | 24043423 | |
151 | Phosphorylation | DTPEVDLYQLQVNTL CCCCEEEEHHHHHHH | 11.60 | 25022875 | |
157 | Phosphorylation | LYQLQVNTLRRYKRH EEHHHHHHHHHHHHH | 23.84 | 20363803 | |
166 | Acetylation | RRYKRHFKLPTRPGL HHHHHHCCCCCCCCC | 47.64 | 30592123 | |
169 | Phosphorylation | KRHFKLPTRPGLNKA HHHCCCCCCCCCCHH | 60.99 | 19413330 | |
175 | Acetylation | PTRPGLNKAQLVEIV CCCCCCCHHHHEEEE | 42.42 | 30592129 | |
175 | Ubiquitination | PTRPGLNKAQLVEIV CCCCCCCHHHHEEEE | 42.42 | 29967540 | |
194 | Acetylation | RSIPVNEKDTLTYFI ECCCCCCCCEEEEEE | 51.30 | 26051181 | |
194 | Sumoylation | RSIPVNEKDTLTYFI ECCCCCCCCEEEEEE | 51.30 | 28112733 | |
194 | Ubiquitination | RSIPVNEKDTLTYFI ECCCCCCCCEEEEEE | 51.30 | - | |
196 | Phosphorylation | IPVNEKDTLTYFIYS CCCCCCCEEEEEEEE | 31.87 | - | |
198 | Phosphorylation | VNEKDTLTYFIYSVK CCCCCEEEEEEEEEC | 20.62 | 27642862 | |
199 | Phosphorylation | NEKDTLTYFIYSVKN CCCCEEEEEEEEECC | 7.35 | - | |
202 | Phosphorylation | DTLTYFIYSVKNDKN CEEEEEEEEECCCCC | 9.49 | 20044836 | |
205 | Sumoylation | TYFIYSVKNDKNKSD EEEEEEECCCCCHHH | 54.19 | - | |
205 | Sumoylation | TYFIYSVKNDKNKSD EEEEEEECCCCCHHH | 54.19 | 28112733 | |
214 | Ubiquitination | DKNKSDLKVDSGVH- CCCHHHCCCCCCCC- | 49.32 | 21963094 | |
214 | Sumoylation | DKNKSDLKVDSGVH- CCCHHHCCCCCCCC- | 49.32 | - | |
214 | Sumoylation | DKNKSDLKVDSGVH- CCCHHHCCCCCCCC- | 49.32 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SAP30_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SAP30_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SAP30_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-104, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-138, ANDMASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-138 ANDTHR-169, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-138 ANDTHR-145, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-138, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-138, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-138, ANDMASS SPECTROMETRY. |